SEC 13F Intelligence

Alphamark Advisors, LLC / UTHR

Alphamark Advisors, LLC’s United Therapeutics Corp Del Position

Does Alphamark Advisors, LLC own United Therapeutics Corp Del (UTHR)? Not currently — the last reported position was 31.4K shares worth $3M in Q3 2019; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$3M
Q3 2019
Shares
31.4K
% of Portfolio
+1.09%
Quarters Held
4
position exited

Position History UTHR

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $4MQ1 ’19Q2 ’19: $3MQ2 ’19Q3 ’19: $3MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 201931.4K$3M+1.09%
Q2 201932.3K$3M+1.11%
Q1 201933.7K$4M+1.67%
Q4 201834.7K$4M+1.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Alphamark Advisors, LLC’s full portfolio or all institutional holders of UTHR.